Fig. 1From: The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr miceTreatment of MRL/lpr mice with CRIg/FH inhibits the appearance of skin lesions. A 20-week old MRL/lpr mice treated by intraperitoneal injection of 10 mg/kg CRIg/FH twice a week since 12 week age; B 20-week old MRL/lpr mice treated by intraperitoneal injection of normal saline, skin lesions are indicated by red arrowsBack to article page